1.Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination:A Case Report
Pricilla Yani GUNAWAN ; Pamela TIFFANI ; Lilie LALISANG
Clinical Psychopharmacology and Neuroscience 2022;20(4):777-780
After more than a year of Coronavirus disease 2019 pandemic, in 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination have been made possible and vaccine was distributed globally. Since then, there have been reports of symptoms following SARS-CoV-2 vaccination, including neurological symptoms of ascending paralysis known as Guillain-Barre syndrome. In this report, we describe the first case of Guillain-Barre syndrome following vaccination in Indonesia. Symptoms of ascending paralysis were of late onset after the first dose, however, were full blown after receiving the second dose followed by left-sided facial paralysis.